全文获取类型
收费全文 | 3337篇 |
免费 | 152篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 69篇 |
妇产科学 | 41篇 |
基础医学 | 651篇 |
口腔科学 | 25篇 |
临床医学 | 221篇 |
内科学 | 928篇 |
皮肤病学 | 54篇 |
神经病学 | 237篇 |
特种医学 | 143篇 |
外科学 | 324篇 |
综合类 | 24篇 |
预防医学 | 241篇 |
眼科学 | 19篇 |
药学 | 258篇 |
中国医学 | 8篇 |
肿瘤学 | 233篇 |
出版年
2023年 | 23篇 |
2022年 | 97篇 |
2021年 | 140篇 |
2020年 | 65篇 |
2019年 | 76篇 |
2018年 | 80篇 |
2017年 | 69篇 |
2016年 | 82篇 |
2015年 | 92篇 |
2014年 | 126篇 |
2013年 | 170篇 |
2012年 | 278篇 |
2011年 | 285篇 |
2010年 | 177篇 |
2009年 | 105篇 |
2008年 | 200篇 |
2007年 | 186篇 |
2006年 | 183篇 |
2005年 | 174篇 |
2004年 | 150篇 |
2003年 | 139篇 |
2002年 | 115篇 |
2001年 | 29篇 |
2000年 | 17篇 |
1999年 | 32篇 |
1998年 | 14篇 |
1997年 | 14篇 |
1995年 | 13篇 |
1994年 | 10篇 |
1993年 | 9篇 |
1992年 | 21篇 |
1991年 | 11篇 |
1990年 | 18篇 |
1988年 | 15篇 |
1986年 | 10篇 |
1985年 | 14篇 |
1984年 | 12篇 |
1982年 | 11篇 |
1981年 | 8篇 |
1979年 | 15篇 |
1978年 | 9篇 |
1977年 | 10篇 |
1974年 | 14篇 |
1973年 | 22篇 |
1972年 | 17篇 |
1971年 | 14篇 |
1970年 | 14篇 |
1969年 | 8篇 |
1967年 | 9篇 |
1966年 | 8篇 |
排序方式: 共有3503条查询结果,搜索用时 0 毫秒
41.
42.
Anna Veverkov Dalibor Preisler Mariia Zimina Tereza Koutov Petr Harcuba Milo Jane
ek Josef Strský 《Materials》2021,14(2)
Low-alloyed zirconium alloys are widely used in nuclear applications due to their low neutron absorption cross-section. These alloys, however, suffer from limited strength. Well-established guidelines for the development of Ti alloys were applied to design new two-phase ternary Zr alloys with improved mechanical properties. Zr-4Sn-4Nb and Zr-8Sn-4Nb alloys have been manufactured by vacuum arc melting, thermo-mechanically processed by annealing, forging, and aging to various microstructural conditions and thoroughly characterized. Detailed Scanning electron microscopy (SEM) analysis showed that the microstructural response of the alloys is rather similar to alpha + beta Ti alloys. Duplex microstructure containing primary alpha phase particles surrounded by lamellar alpha + beta microstructure can be achieved by thermal processing. Mechanical properties strongly depend on the previous treatment. Ultimate tensile strength exceeding 700 MPa was achieved exceeding the strength of commercial Zr alloys for nuclear applications by more than 50%. Such an improvement in strength more than compensates for the increased neutron absorption cross-section. This study aims to exploit the potential of alpha + beta Zr alloys for nuclear applications. 相似文献
43.
44.
45.
Nikolaos G. Papadopoulos Adnan ustovi Michael D. Cabana Sharon D. Dell Antoine Deschildre Gunilla Hedlin Elham Hossny Peter Le Souëf Paolo M. Matricardi Antonio Nieto Wanda Phipatanakul Paulo M. Pitrez Petr Pohunek Marcela Gavornikova Xavier Jaumont David B. Price 《Pediatric allergy and immunology》2019,30(1):7-16
46.
47.
Genomewide profiling of copy‐number alteration in monoclonal gammopathy of undetermined significance
下载免费PDF全文
![点击此处可从《European journal of haematology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Aneta Mikulasova Jan Smetana Marketa Wayhelova Helena Janyskova Viera Sandecka Zuzana Kufova Martina Almasi Jiri Jarkovsky Evzen Gregora Petr Kessler Marek Wrobel Brian A. Walker Christopher P. Wardell Gareth J. Morgan Roman Hajek Petr Kuglik 《European journal of haematology》2016,97(6):568-575
Monoclonal gammopathy of undetermined significance (MGUS) is a benign condition with an approximate 1% annual risk of symptomatic plasma cell disorder development, mostly to multiple myeloma (MM). We performed genomewide screening of copy‐number alterations (CNAs) in 90 MGUS and 33 MM patients using high‐density DNA microarrays. We identified CNAs in a smaller proportion of MGUS (65.6%) than in MM (100.0%, P = 1.31 × 10?5) and showed median number of CNAs is lower in MGUS (3, range 0–22) than in MM (13, range 4–38, P = 1.82 × 10?10). In the MGUS cohort, the most frequent losses were located at 1p (5.6%), 6q (6.7%), 13q (30.0%), 14q (14.4%), 16q (8.9%), 21q (5.6%), and gains at 1q (23.3%), 2p (6.7%), 6p (13.3%), and Xq (7.8%). Hyperdiploidy was detected in 38.9% of MGUS cases, and the most frequent whole chromosome gains were 3 (25.6%), 5 (23.3%), 9 (37.8%), 15 (23.3%), and 19 (32.2%). We also identified CNAs such as 1p, 6q, 8p, 12p, 13q, 16q losses, 1q gain and hypodiploidy, which are potentially associated with an adverse prognosis in MGUS. In summary, we showed that MGUS is similar to MM in that it is a genetically heterogeneous disorder, but overall cytogenetic instability is lower than in MM, which confirms that genetic abnormalities play important role in monoclonal gammopathies. 相似文献
48.
Petr Widimský Richard Rokyta Josef Št׳ásek Jan Bělohlávek Pavel Červinka Petr Kala 《Cor et vasa》2013,55(3):e225-e227
The Czech Society of Cardiology is proposing here the new classification of acute coronary syndromes at the time of the first medical contact. The proposal suggests to remove the terms “ST elevation myocardial infarction” and “non-ST elevation acute coronary syndrome” and to replace these terms by “acute coronary syndrome with ongoing myocardial ischemia” and “acute coronary syndrome without ongoing myocardial ischemia”. The proposed new classification better reflects current treatment approaches and will facilitate the decision making at the first medical contact. 相似文献
49.
Lenka Sedlarikova Barbora Gromesova Veronika Kubaczkova Lenka Radova Jana Filipova Jiri Jarkovsky Lucie Brozova Roberta Velichova Martina Almasi Miroslav Penka Renata Bezdekova Martin Stork Zdenek Adam Ludek Pour Marta Krejci Petr Kuglík Roman Hajek Sabina Sevcikova 《European journal of haematology》2017,99(3):223-233
50.
Martin Haluzik Milos Mraz Petr Kopecky Michal Lips Stepan Svacina 《Journal of diabetes science and technology》2014,8(4):652-657
During the last 2 decades, the treatment of hyperglycemia in critically ill patients has become one of the most discussed topics in the intensive medicine field. The initial data suggesting significant benefit of normalization of blood glucose levels in critically ill patients using intensive intravenous insulin therapy have been challenged or even neglected by some later studies. At the moment, the need for glucose control in critically ill patients is generally accepted yet the target glucose values are still the subject of ongoing debates. In this review, we summarize the current data on the benefits and risks of tight glucose control in critically ill patients focusing on the novel technological approaches including continuous glucose monitoring and its combination with computer-based algorithms that might help to overcome some of the hurdles of tight glucose control. Since increased risk of hypoglycemia appears to be the major obstacle of tight glucose control, we try to put forward novel approaches that may help to achieve optimal glucose control with low risk of hypoglycemia. If such approaches can be implemented in real-world practice the entire concept of tight glucose control may need to be revisited. 相似文献